We are a Digital Biotech Company devoted to the research, design, development and marketing of prescription digital therapeutics
Our products are based on evidence generated through clinical trials.
Our research areas are mental Health, eating disorders and cardio-metabolic diseases.
We develop our products following a participatory design approach, involving patients, caregivers and healthcare professionals as partners.
We aim to be a partner of patients and healthcare providers associations, healthcare organizations and institutions to support the development of digital therapeutics in order to offer new hopes for health to patients and more sustainability to healthcare systems
Milan and London – November 13, 2019 Digital Therapeutics are an emerging class of medical interventions to treat chronic diseases and dependence daVinci Digital Therapeutics
The first project to develop a new blended prescription Digital Therapeutic to treat Major Depressive Disorder has been started.
Raising awareness about digital therapy, helping to clarify the pathway to reimbursement and integration into healthcare.
September 2020, Rome
Engineer from the Politecnico of Milan, with over 15 years of experience in multinational medical device companies and management of advanced technology companies.
Medical Doctor, with over 35 years of experience in medical research, development of drugs and advanced technologies in a pharmaceutical company and a scientific foundation
Psychiatrist, expert in Digital Psychiatry and leading Science Blogger, with clinical experience in mental health disorders and skills in advanced digital technology and communication